Cannabinoids and Chronic Liver Diseases

Nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease (ALD), and viral hepatitis are the main causes of morbidity and mortality related to chronic liver diseases (CLDs) worldwide. New therapeutic approaches to prevent or reverse these liver disorders are thus emerging. Although the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mboumba Bouassa, Ralph-Sydney, Sebastiani, Giada, Di Marzo, Vincenzo, Jenabian, Mohammad-Ali, Costiniuk, Cecilia T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408890/
https://www.ncbi.nlm.nih.gov/pubmed/36012687
http://dx.doi.org/10.3390/ijms23169423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408890/
https://www.ncbi.nlm.nih.gov/pubmed/36012687
http://dx.doi.org/10.3390/ijms23169423

Ejemplares similares